PT Diagnos Laboratorium Utama (DGNS.JK) Earnings Analysis
PT Diagnos Laboratorium Utama (DGNS.JK) has no confirmed upcoming earnings date. Trailing P/E 88.06.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DGNS.JK next report earnings?
No confirmed upcoming earnings date is currently scheduled for DGNS.JK. This page updates as the calendar is published.
DGNS.JK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-30 | 0.2228 IDR | n/a | n/a | n/a |
| 2024-09-29 | -0.55116 IDR | n/a | n/a | n/a |
DGNS.JK valuation and analyst view
| Trailing P/E | 88.06 |
|---|---|
| Trailing EPS | 2.677 IDR |
| Price / book | 1.46 |
| Dividend yield | 0.00% |
| Market cap | 316.25B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PT Diagnos Laboratorium Utama (DGNS.JK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for DGNS.JK. This page updates as the calendar is published.
Did DGNS.JK beat earnings last quarter?
Consensus estimate data was not available for DGNS.JK's 2024-12-30 report.
What is DGNS.JK's current P/E ratio and EPS?
DGNS.JK trades at a trailing P/E of 88.06 on trailing EPS of 2.6770038144 IDR.
What do analysts rate DGNS.JK?
DGNS.JK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.